Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Tuberculosis in the tropics.

Gary Maartens1, Nulda Beyers

  • 1Infectious Diseases Unit, Department of Medicine, UCT Health Sciences Faculty, Anzio Road, Observatory 7925, South Africa. gary@curie.uct.ac.za

Clinics in Chest Medicine
|July 3, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Risk of unnatural death following self-harm in South Africa: development and validation of multivariable prognostic models.

BMJ mental health·2026
Same author

A Pragmatic Trial of a 6-Month Strategy for Rifampicin-Resistant Tuberculosis.

The New England journal of medicine·2026
Same author

Bedaquiline reloading strategies following interruptions during daily dosing.

Antimicrobial agents and chemotherapy·2026
Same author

Whole genome sequencing precision medicine strategy to shorten treatment for rifampicin-resistant tuberculosis (SMARTT): a pragmatic, randomised, single-blind phase 4 trial.

The Lancet. Respiratory medicine·2026
Same author

Determinants of drop-offs in the targeted universal tuberculosis testing care cascade among people with HIV in rural and urban facilities in South Africa.

Southern African journal of HIV medicine·2026
Same author

Exposure-QTc modeling of bedaquiline, pretomanid, and clofazimine in adults with tuberculosis.

Antimicrobial agents and chemotherapy·2026
Same journal

Pneumonia Reimagined: Host, Microbe, and the Shifting Landscape of Disease.

Clinics in chest medicine·2026
Same journal

Advocacy in Pneumonia.

Clinics in chest medicine·2026
Same journal

Vaccines Against Pneumonia: Current Updates.

Clinics in chest medicine·2026
Same journal

Non-antibiotic Treatments for Pneumonia: Host-Directed Therapies, Next-Steps and Future Directions.

Clinics in chest medicine·2026
Same journal

Customizing Antibiotic Treatment for Pneumonia: Can We Have a Single Unified Algorithm for All Types of Pneumonia?

Clinics in chest medicine·2026
Same journal

The Role of Complex Digital Interventions to Improve Pneumonia Care.

Clinics in chest medicine·2026
See all related articles

Tropical countries face a high tuberculosis (TB) burden, especially affecting children. Improving TB control requires better diagnostics, accessible rifampin therapy, and enhanced Directly Observed Treatment, Short-course (DOTS) strategies, particularly for smear-negative cases.

Area of Science:

  • Tropical Medicine
  • Infectious Diseases
  • Public Health

Background:

  • Tuberculosis (TB) disproportionately affects tropical countries, with young children and HIV-infected individuals at high risk.
  • Pulmonary cavities in adults are primary TB transmission sources, while smear-negative TB poses challenges in resource-limited settings.
  • The HIV pandemic exacerbates TB incidence in sub-Saharan Africa, complicating diagnosis and treatment.

Purpose of the Study:

  • To review the current challenges and strategies for tuberculosis control in tropical regions.
  • To highlight the difficulties posed by smear-negative TB in resource-poor settings.
  • To discuss the role of Directly Observed Treatment, Short-course (DOTS) and potential improvements in TB management.

Main Methods:

Related Experiment Videos

  • Literature review of TB epidemiology and control strategies in tropical countries.
  • Analysis of diagnostic challenges, particularly for smear-negative TB.
  • Evaluation of treatment regimens, including rifampin-based therapy and DOTS implementation.

    • Main Results:

    • Smear-negative TB is a growing concern due to limited access to mycobacterial culture and histopathology.
    • While rifampin-based short-course therapies are becoming more accessible, DOTS targets remain unmet.
    • Innovative, low-cost therapy supervision methods using community members are emerging.
    • Preventive therapy is restricted to high-risk groups, and an improved TB vaccine is crucial.

    Conclusions:

    • Effective TB control in tropical regions necessitates addressing smear-negative cases and improving DOTS adherence.
    • Enhanced diagnostic capabilities and accessible, supervised treatment are vital.
    • Development of an improved TB vaccine holds significant potential for global TB eradication.